Transarterial Chemoembolization Combined with Atezolizumab Plus Bevacizumab or Lenvatinib for Unresectable Hepatocellular Carcinoma: A Propensity Score Matched Study
-
Published:2023-07
Issue:
Volume:Volume 10
Page:1195-1206
-
ISSN:2253-5969
-
Container-title:Journal of Hepatocellular Carcinoma
-
language:en
-
Short-container-title:JHC
Author:
Zhao Chenghao,
Xiang Zhanwang,
Li Mingan,
Wang HaofanORCID,
Liu Huan,
Yan Huzheng,
Huang MingshengORCID
Publisher
Informa UK Limited